Christopher Davis - Davis Advisors
Holding/activity history for Novartis AG (NVS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2022 Q4 | 0 | 0 | Sell 100.00% | 0.02 | |
| 2022 Q3 | 28,943 | 0.02 | $76.01 | ||
| 2022 Q2 | 28,943 | 0.02 | Reduce 11.37% | 0.00 | $84.55 |
| 2022 Q1 | 32,656 | 0.01 | Reduce 24.12% | 0.00 | $87.76 |
| 2021 Q4 | 43,035 | 0.02 | Reduce 4.30% | 0.00 | $87.46 |
| 2021 Q3 | 44,968 | 0.02 | Reduce 4.09% | 0.00 | $81.77 |
| 2021 Q2 | 46,888 | 0.02 | Add 5.55% | 0.00 | $91.24 |
| 2021 Q1 | 44,424 | 0.02 | Add 7.68% | 0.00 | $85.47 |
| 2020 Q4 | 41,256 | 0.02 | Add 6.20% | 0.00 | $94.43 |
| 2020 Q3 | 38,848 | 0.02 | Add 2.26% | 0.00 | $86.95 |
| 2020 Q2 | 37,988 | 0.02 | Add 36.45% | 0.01 | $87.34 |
| 2020 Q1 | 27,840 | 0.02 | Add 6.58% | 0.00 | $82.44 |
| 2019 Q4 | 26,120 | 0.01 | $94.68 |